Susquehanna International Group
IMGN

Susquehanna International Group’s Immunogen Inc IMGN Stock Holding History

Susquehanna International Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-376,000
Closed -$11.1M – 13801
2023
Q4 		$11.1M Sell
376,000
-800
-0.2% -$15.9K ﹤0.01% 2492
2023
Q3 		$5.98M Buy
376,800
+69,700
+23% +$1.16M ﹤0.01% 3242
2023
Q2 		$5.79M Buy
307,100
+109,600
+55% +$1.29M ﹤0.01% 3299
2023
Q1 		$758K Sell
197,500
-2,600
-1% -$11.1K ﹤0.01% 7524
2022
Q4 		$992K Buy
200,100
+78,700
+65% +$427K ﹤0.01% 6203
2022
Q3 		$580K Sell
121,400
-5,900
-5% -$31.1K ﹤0.01% 8087
2022
Q2 		$573K Buy
127,300
+91,900
+260% +$399K ﹤0.01% 7921
2022
Q1 		$169K Sell
35,400
-176,400
-83% -$977K ﹤0.01% 11444
2021
Q4 		$1.57M Sell
211,800
-152,200
-42% -$946K ﹤0.01% 6103
2021
Q3 		$2.06M Buy
364,000
+114,000
+46% +$659K ﹤0.01% 5765
2021
Q2 		$1.65M Buy
250,000
+21,600
+9% +$151K ﹤0.01% 6383
2021
Q1 		$1.85M Sell
228,400
-8,500
-4% -$69.4K ﹤0.01% 6114
2020
Q4 		$1.53M Buy
236,900
+115,100
+94% +$671K ﹤0.01% 5703
2020
Q3 		$438K Buy
121,800
+51,600
+74% +$208K ﹤0.01% 7951
2020
Q2 		$323K Sell
70,200
-120,500
-63% -$512K ﹤0.01% 8231
2020
Q1 		$650K Buy
190,700
+62,100
+48% +$271K ﹤0.01% 6370
2019
Q4 		$657K Buy
128,600
+52,400
+69% +$178K ﹤0.01% 6399
2019
Q3 		$184K Sell
76,200
-369,100
-83% -$980K ﹤0.01% 9177
2019
Q2 		$966K Sell
445,300
-252,800
-36% -$598K ﹤0.01% 5742
2019
Q1 		$1.89M Buy
698,100
+355,800
+104% +$1.54M ﹤0.01% 3829
2018
Q4 		$1.64M Buy
342,300
+260,000
+316% +$1.58M ﹤0.01% 3818
2018
Q3 		$779K Sell
82,300
-179,800
-69% -$1.73M ﹤0.01% 5724
2018
Q2 		$2.55M Sell
262,100
-257,400
-50% -$2.71M ﹤0.01% 3636
2018
Q1 		$5.46M Buy
519,500
+407,900
+366% +$4.03M ﹤0.01% 2436
2017
Q4 		$715K Sell
111,600
-151,900
-58% -$937K ﹤0.01% 5905
2017
Q3 		$2.02M Sell
263,500
-49,200
-16% -$327K ﹤0.01% 3894
2017
Q2 		$2.22M Buy
312,700
+213,100
+214% +$975K ﹤0.01% 3733
2017
Q1 		$385K Buy
99,600
+47,600
+92% +$139K ﹤0.01% 6961
2016
Q4 		$106K Sell
52,000
-300
-0.6% -$602 ﹤0.01% 9057
2016
Q3 		$140K Sell
52,300
-51,800
-50% -$151K ﹤0.01% 7809
2016
Q2 		$321K Buy
104,100
+10,200
+11% +$64K ﹤0.01% 6846
2016
Q1 		$800K Sell
93,900
-33,500
-26% -$283K ﹤0.01% 5534
2015
Q4 		$1.73M Buy
127,400
+10,400
+9% +$128K ﹤0.01% 4342
2015
Q3 		$1.12M Sell
117,000
-134,000
-53% -$1.96M ﹤0.01% 5490
2015
Q2 		$3.61M Buy
251,000
+185,600
+284% +$2.04M ﹤0.01% 3515
2015
Q1 		$585K Sell
65,400
-13,100
-17% -$94.9K ﹤0.01% 6811
2014
Q4 		$479K Sell
78,500
-6,200
-7% -$56.7K ﹤0.01% 7293
2014
Q3 		$897K Sell
84,700
-35,600
-30% -$403K ﹤0.01% 6126
2014
Q2 		$1.43M Sell
120,300
-32,400
-21% -$407K ﹤0.01% 5328
2014
Q1 		$2.28M Buy
152,700
+30,700
+25% +$484K ﹤0.01% 4110
2013
Q4 		$1.79M Sell
122,000
-600
-0.5% -$9.22K ﹤0.01% 4486
2013
Q3 		$2.09M Sell
122,600
-127,200
-51% -$2.24M ﹤0.01% 4019
2013
Q2 		$4.14M Buy
+249,800
New +$4.05M ﹤0.01% 2864

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Susquehanna International Group's IMGN Position: Q1 2024 in Review

Susquehanna International Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 736,034 shares — an estimated $21.8M sold.

Susquehanna International Group first reported a position in IMGN in Q2 2013 and held it in 37 quarters. The position peaked at $24.8M in Q2 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Susquehanna International Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Susquehanna International Group sold 736,034 Immunogen Inc shares in Q1 2024, an estimated $21.8M.
  • Susquehanna International Group first reported a position in Immunogen Inc in Q2 2013 and held it in 37 quarters.
  • Susquehanna International Group's Immunogen Inc position peaked at $24.8M in Q2 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.